KNEAT.COM INC (KSI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:KSI - CA4988241010 - Common Stock
4.87 CAD
+0.05 (+1.04%)
Overall KSI gets a fundamental rating of 4 out of 10. We evaluated KSI against 8 industry peers in the Health Care Technology industry. The financial health of KSI is average, but there are quite some concerns on its profitability. KSI is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
KSI had negative earnings in the past year.
KSI had a positive operating cash flow in the past year.
In the past 5 years KSI always reported negative net income.
In multiple years KSI reported negative operating cash flow during the last 5 years.
1.2 Ratios
KSI has a better Return On Assets (-0.90%) than 75.00% of its industry peers.
KSI has a better Return On Equity (-1.80%) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.8% | ||
| ROIC | N/A |
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
KSI has a Gross Margin of 75.20%. This is in the better half of the industry: KSI outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of KSI has grown nicely.
The Profit Margin and Operating Margin are not available for KSI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
2. Health
2.1 Basic Checks
KSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KSI has more shares outstanding
The number of shares outstanding for KSI has been increased compared to 5 years ago.
KSI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.95 indicates that KSI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.95, KSI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that KSI is not too dependend on debt financing.
KSI's Debt to Equity ratio of 0.34 is fine compared to the rest of the industry. KSI outperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.95 |
ROIC/WACCN/A
WACC7.31%
2.3 Liquidity
A Current Ratio of 1.71 indicates that KSI should not have too much problems paying its short term obligations.
KSI has a Current ratio of 1.71. This is in the better half of the industry: KSI outperforms 62.50% of its industry peers.
KSI has a Quick Ratio of 1.71. This is a normal value and indicates that KSI is financially healthy and should not expect problems in meeting its short term obligations.
KSI's Quick ratio of 1.71 is fine compared to the rest of the industry. KSI outperforms 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
KSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.00%, which is quite impressive.
The Revenue has grown by 33.27% in the past year. This is a very strong growth!
KSI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 65.43% yearly.
EPS 1Y (TTM)80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)33.27%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%26.23%
3.2 Future
The Earnings Per Share is expected to grow by 30.10% on average over the next years. This is a very strong growth
KSI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.40% yearly.
EPS Next Y87.88%
EPS Next 2Y15.47%
EPS Next 3Y30.1%
EPS Next 5YN/A
Revenue Next Year29.65%
Revenue Next 2Y27.44%
Revenue Next 3Y26.73%
Revenue Next 5Y30.4%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for KSI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KSI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
KSI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KSI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 98.47 |
4.3 Compensation for Growth
KSI's earnings are expected to grow with 30.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y30.1%
5. Dividend
5.1 Amount
No dividends for KSI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:KSI (12/24/2025, 7:00:00 PM)
4.87
+0.05 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners17.4%
Inst Owner ChangeN/A
Ins Owners9.93%
Ins Owner ChangeN/A
Market Cap464.31M
Revenue(TTM)60.00M
Net Income(TTM)-1.19M
Analysts80
Price Target6.73 (38.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)87.62%
Min EPS beat(2)75.25%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)88.86%
Min EPS beat(4)0.99%
Max EPS beat(4)179.21%
EPS beat(8)8
Avg EPS beat(8)63.36%
EPS beat(12)11
Avg EPS beat(12)48.68%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.48%
Min Revenue beat(2)-5.77%
Max Revenue beat(2)-5.2%
Revenue beat(4)0
Avg Revenue beat(4)-4.23%
Min Revenue beat(4)-5.77%
Max Revenue beat(4)-1.71%
Revenue beat(8)3
Avg Revenue beat(8)-1.32%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)8
Avg Revenue beat(16)2.68%
PT rev (1m)-16.46%
PT rev (3m)-16.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.99%
EPS NY rev (1m)56.36%
EPS NY rev (3m)74.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.96%
Revenue NY rev (1m)-1.55%
Revenue NY rev (3m)-1.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 7.74 | ||
| P/FCF | N/A | ||
| P/OCF | 32.69 | ||
| P/B | 7.01 | ||
| P/tB | 21.42 | ||
| EV/EBITDA | 98.47 |
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.15
OCFY3.06%
SpS0.63
BVpS0.69
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.8% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.2% | ||
| FCFM | N/A |
ROA(3y)-15.47%
ROA(5y)-16.49%
ROE(3y)-45.71%
ROE(5y)-39.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.7%
GM growth 5Y11.01%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.16 | ||
| Cap/Depr | 168.83% | ||
| Cap/Sales | 35.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 321.96% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | 3.95 |
F-Score6
WACC7.31%
ROIC/WACCN/A
Cap/Depr(3y)219.46%
Cap/Depr(5y)224.77%
Cap/Sales(3y)49.12%
Cap/Sales(5y)62.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y87.88%
EPS Next 2Y15.47%
EPS Next 3Y30.1%
EPS Next 5YN/A
Revenue 1Y (TTM)33.27%
Revenue growth 3Y46.7%
Revenue growth 5Y65.43%
Sales Q2Q%26.23%
Revenue Next Year29.65%
Revenue Next 2Y27.44%
Revenue Next 3Y26.73%
Revenue Next 5Y30.4%
EBIT growth 1Y-2.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year229.41%
EBIT Next 3Y75.51%
EBIT Next 5Y48.14%
FCF growth 1Y56.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6327.58%
OCF growth 3Y61.83%
OCF growth 5YN/A
KNEAT.COM INC / KSI.CA FAQ
What is the fundamental rating for KSI stock?
ChartMill assigns a fundamental rating of 4 / 10 to KSI.CA.
Can you provide the valuation status for KNEAT.COM INC?
ChartMill assigns a valuation rating of 2 / 10 to KNEAT.COM INC (KSI.CA). This can be considered as Overvalued.
What is the profitability of KSI stock?
KNEAT.COM INC (KSI.CA) has a profitability rating of 3 / 10.
How financially healthy is KNEAT.COM INC?
The financial health rating of KNEAT.COM INC (KSI.CA) is 5 / 10.